1. Autoimmune diseases during treatment with immunomodulatory drugs in multiple myeloma: selective occurrence after lenalidomide. Issue 9 (September 2014) Authors: Montefusco, Vittorio; Galli, Monica; Spina, Francesco; Stefanoni, Paola; Mussetti, Alberto; Perrone, Giulia; De Philippis, Chiara; Dalto, Serena; Maura, Francesco; Bonini, Chiara; Rezzonico, Francesca; Pennisi, Martina; Roncari, Luisa; Soldarini, Martina; Dodero, Anna; Farina, Lucia; Cocito, Fede... Journal: Leukemia & lymphoma Issue: Volume 55:Issue 9(2014:Sep.) Page Start: 2032 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study. Issue 3 (4th March 2017) Authors: Pozzi, Samantha; Gentile, Massimo; Sacchi, Stefano; Marcheselli, Raffaella; Corso, Alessandro; Cocito, Federica; Musto, Pellegrino; Guarini, Attilio; Minoia, Carla; Vincelli, Iolanda; Ria, Roberto; Rivolti, Elena; Mele, Giuseppe; Bari, Alessia; Mazzone, Carla; Badiali, Stefania; Marcheselli, Luig... Journal: Leukemia & lymphoma Issue: Volume 58:Issue 3(2017) Page Start: 552 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Central nervous system involvement by multiple myeloma: A multi‐institutional retrospective study of 172 patients in daily clinical practice. Issue 6 (24th April 2016) Authors: Jurczyszyn, Artur; Grzasko, Norbert; Gozzetti, Alessandro; Czepiel, Jacek; Cerase, Alfonso; Hungria, Vania; Crusoe, Edvan; Silva Dias, Ana Luiza Miranda; Vij, Ravi; Fiala, Mark A.; Caers, Jo; Rasche, Leo; Nooka, Ajay K.; Lonial, Sagar; Vesole, David H.; Philip, Sandhya; Gangatharan, Shane; Druzd‐... Journal: American journal of hematology Issue: Volume 91:Issue 6(2016:Jun.) Page Start: 575 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Corneal sub-basal neural damage pattern in multiple myeloma patients treated with bortezomib: an in vivo confocal study. Issue 12 (2nd December 2015) Authors: Cocito, Federica; Ricciardelli, Gabriella; Mangiacavalli, Silvia; Pompa, Alessandra; Pochintesta, Lara; Ferretti, Virginia; Ceccuzzi, Roberto; Cazzola, Mario; Bianchi, Paolo Emilio; Corso, Alessandro Journal: Leukemia & lymphoma Issue: Volume 56:Issue 12(2015:Dec.) Page Start: 3440 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Correlation between burden of 17P13.1 alteration and rapid escape to plasma cell leukaemia in multiple myeloma. (30th May 2013) Authors: Mangiacavalli, Silvia; Pochintesta, Lara; Cocito, Federica; Pompa, Alessandra; Bernasconi, Paolo; Cazzola, Mario; Corso, Alessandro Journal: British journal of haematology Issue: Volume 162:Number 4(2013:Aug.) Page Start: 555 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Duvelisib as bridge to allotransplantation in refractory peripheral T-cell lymphoma with T-follicular helper phenotype: case report. Issue 6 (December 2021) Authors: Lolli, Ginevra; Casadei, Beatrice; Pellegrini, Cinzia; Argnani, Lisa; Cocito, Federica; Zinzani, Pier Luigi Journal: Tumori Issue: Volume 107:Issue 6(2021) Page Start: NP105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Good clinical activity and favorable toxicity profile of once weekly bortezomib, fotemustine, and dexamethasone (B‐MuD) for the treatment of relapsed multiple myeloma. Issue 2 (8th December 2012) Authors: Mangiacavalli, Silvia; Pochintesta, Lara; Pascutto, Cristiana; Cocito, Federica; Cazzola, Mario; Corso, Alessandro Journal: American journal of hematology Issue: Volume 88:Issue 2(2013:Feb.) Page Start: 102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Humoral and cellular immune response in patients with hematological disorders after two doses of BNT162b2 mRNA COVID‐19 vaccine: A single‐center prospective observational study (NCT05074706). Issue 4 (30th August 2022) Authors: Bossi, Elisa; Aroldi, Andrea; Borin, Lorenza Maria; Verga, Luisa; Fontana, Diletta; Cocito, Federica; Manghisi, Beatrice; Rindone, Giovanni; Cavalca, Fabrizio; Ripamonti, Alessia; Raggi, Monica; Malandrin, Sergio Maria Ivano; Cavallero, Annalisa; Antolini, Laura; Bonardi, Diego; Piazza, Rocco Gio... Journal: EJHaem Issue: Volume 3:Issue 4(2022) Page Start: 1201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Implemented myeloma management with whole-body low-dose CT scan: a real life experience. Issue 7 (2nd July 2016) Authors: Mangiacavalli, Silvia; Pezzatti, Sara; Rossini, Fausto; Doni, Elisa; Cocito, Federica; Bolis, Silvia; Corso, Alessandro Journal: Leukemia & lymphoma Issue: Volume 57:Issue 7(2016:Jul.) Page Start: 1539 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Long-term control of extensive refractory chronic graft versus host disease in a multiple myeloma relapsing after allogeneic transplant. A case report. Issue 11 (2nd November 2017) Authors: Cocito, Federica; Mangiacavalli, Silvia; Bernasconi, Paolo; Colombo, Anna A.; Caldera, Daniela; Cartia, Claudio S.; Ganzetti, Maya; Troletti, Daniela; Cazzola, Mario; Corso, Alessandro Journal: Leukemia & lymphoma Issue: Volume 58:Issue 11(2017) Page Start: 2770 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗